A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema.
Phase of Trial: Phase II
Latest Information Update: 02 Sep 2016
At a glance
- Drugs Nepafenac (Primary)
- Indications Ocular pain
- Focus Therapeutic Use
- 11 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Jun 2012 Planned End Date changed from 1 May 2012 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 14 Nov 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.